Advertisement

Topics

"Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients" Drugs and Medication Database

18:50 EST 21st January 2019 | BioPortfolio

Here are the most relevant "Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients" Drugs and Medications that we have found in our database.

More Information about "Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients" on BioPortfolio

We have published hundreds of Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients news stories on BioPortfolio along with dozens of Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients Clinical Trials and PubMed Articles about Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients Companies in our database. You can also find out about relevant Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients Drugs and Medications on this site too.

Showing "Prophylactic Therapy Cytomegalovirus Liver Transplant Recipients" Drugs and Medications 1–25 of 172

Probably Relevant

Mycophenolate mofetil [Cadila Healthcare Limited]

These highlights do not include all the information needed to use Mycophenolate Mofetil for Injection, USP safely and effectively. See full prescribing information for Mycophenolate Mofetil for Injection, USP Initial U.S. Approval: 1995

Mycophenolate mofetil [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use Mycophenolate Mofetil for Injection, USP safely and effectively. See full prescribing information for Mycophenolate Mofetil for Injection, USP Initial U.S. Approval: 1995

Mycophenolate mofetil [Teva Pharmaceuticals USA, Inc.]

These highlights do not include all the information needed to use MYCOPHENOLATE MOFETIL CAPSULES safely and effectively. See full prescribing information for MYCOPHENOLATE MOFETIL CAPSULES. MYCOPHENOLATE MOFETIL capsules, for oral use Initial U.S. Appr

Mycophenolate mofetil [Sandoz Inc]

These highlights do not include all the information needed to use MYCOPHENOLATE MOFETIL safely and effectively. See full prescribing information for MYCOPHENOLATE MOFETIL.MYCOPHENOLATE mofetil capsules, for oral useMYCOPHENOLATE mofetil tablets, for oral

Nulojix [E.R. Squibb & Sons, L.L.C.]

These highlights do not include all the information needed to use NULOJIX safely and effectively. See full prescribing information for NULOJIX. NULOJIX (belatacept) for injection, for intravenous useInitial U.S. Approval: 2011

Cellcept [Genentech, Inc.]

These highlights do not include all the information needed to use CELLCEPT safely and effectively. See full prescribing information for CELLCEPT CELLCEPT (mycophenolate mofetil) capsules, for oral useCELLCEPT (mycophenolate mofetil) tablets, for oral useC

Ganciclovir [EXELA PHARMA SCIENCES, LLC]

These highlights do not include all the information needed to use GANCICLOVIR INJECTION safely and effectively. See full prescribing information for GANCICLOVIR INJECTION. GANCICLOVIR INJECTION, for intravenous useInitial U.S. Approval: 1989 

Possibly Relevant

Sirolimus [American Health Packaging]

These highlights do not include all the information needed to use SIROLIMUS TABLETS safely and effectively. See full prescribing information for SIROLIMUS TABLETS. SIROLIMUS tablets, for oral use Initial U.S. Approval: 1999

Sirolimus [Greenstone LLC]

These highlights do not include all the information needed to use SIROLIMUS safely and effectively. See full prescribing information for SIROLIMUS. SIROLIMUS tablets, for oral use Initial U.S. Approval: 1999

Ganciclovir [Fresenius Kabi USA, LLC]

NA

Ganciclovir [Fresenius Kabi USA, LLC]

Ganciclovir for Injection, USP

Ganciclovir [Sagent Pharmaceuticals]

These highlights do not include all the information needed to use GANCICLOVIR INJECTION safely and effectively. See full prescribing information for GANCICLOVIR INJECTION. GANCICLOVIR injection, for intravenous useInitial U.S. Approval: 1989

Ganciclovir [Par Pharmaceutical, Inc.]

These highlights do not include all the information needed to use GANCICLOVIR FOR INJECTION safely and effectively. See full prescribing information for GANCICLOVIR FOR INJECTION. Ganciclovir for injection, for intravenous useInitial U.S. Approval: 1989

Cytovene [Genentech, Inc.]

These highlights do not include all the information needed to use CYTOVENE-IV safely and effectively. See full prescribing information for CYTOVENE-IV. CYTOVENE-IV (ganciclovir sodium) for injection, for intravenous use Initial U.S. Approval: 1989

Myfortic [Novartis Pharmaceuticals Corporation]

These highlights do not include all the information needed to use MYFORTIC safely and effectively. See full prescribing information for MYFORTIC. MYFORTIC® (mycophenolic acid) delayed-release tablets, for oral use Initial U.S. Approval: 2004

Ganciclovir [Pharmascience Inc.]

These highlights do not include all the information needed to use GANCICLOVIR INJECTION safely and effectively. See full prescribing information for GANCICLOVIR INJECTION.GANCICLOVIR injection, for intravenous useInitial U.S. Approval: 1989

Mycophenolic acid [Apotex Corp]

These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS. MYCOPHENOLIC ACID delayed-release tablets,

Mycophenolic acid [Major Pharmaceuticals]

These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS. MYCOPHENOLIC ACID delayed-release tablets,

Thymoglobulin [Genzyme Corporation]

These highlights do not include all the information needed to use THYMOGLOBULIN safely and effectively. See full prescribing information for THYMOGLOBULIN. THYMOGLOBULIN (anti-thymocyte globulin [rabbit]) for intravenous use Initial U.S. Approval: 1998

Mycophenolic acid [American Health Packaging]

These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS. MYCOPHENOLIC ACID delayed-release tablets,

Mycophenolic acid [Golden State Medical Supply, Inc.]

MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS. M

Mycophenolic acid [Accord Healthcare Inc.]

These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED RELEASE TABLETS. MYCOPHENOLIC ACID delayed release tablets,

Cyclosporine [Mayne Pharma Inc.]

Cyclosporine Capsules, USP [MODIFIED] (Soft Gelatin) Cyclosporine ORAL SOLUTION, USP [MODIFIED]

Gengraf [AbbVie Inc.]

GENGRAF Capsules (cyclosporine capsules, USP [MODIFIED])

Gengraf [AbbVie Inc.]

GENGRAF ORAL SOLUTION(cyclosporine oral solution, USP [MODIFIED])



Advertisement
Quick Search
Advertisement
Advertisement